The Hugh Kaul Precision Medicine Institute (PMI) team has partnered with Every Cure on a groundbreaking project to build a large drug-repurposing database. The project, called ML/AI-enabled Therapeutic Repurposing In eXtended uses (MATRIX), received a contract from the Advanced Research Projects Agency for Health (ARPA-H) for up to $48 million, announced earlier this year at a White House event.

Heersink School of Medicine awarded nine staff members as the 2024 Dean’s Excellence Awards for Staff winners. Individuals selected for this honor showcased outstanding accomplishments beyond their daily duties and contributed considerably to Heersink’s core mission areas – education, clinical care, and basic, translational, and clinical research.

Camerron Crowder, Ph.D., assistant professor in the UAB Department of Neurobiology and assistant director of the Hugh Kaul Precision Medicine Institute (PMI), offers a unique research opportunity for undergraduate students by teaching the PMI research process, how to develop animal models, and the use of artificial intelligence to identify treatment options through courses in the Undergraduate Neuroscience Program.

A cluster analysis in the Deep South showed that racial background significantly influences diabetes subtype distribution.

This investment marks a critical step forward in harnessing cutting-edge technology to revolutionize the accessibility and application of biomedical data science.

University of Alabama at Birmingham (UAB) faculty members recently participated in the AI in Medicine and Healthcare Symposium at Maastricht University, which brought together experts and stakeholders to discuss the role of artificial intelligence (AI) in transforming health care.

The American College of Physicians Alabama Chapter recently held its annual Winter Meeting at UAB’s new Active Learning Center in Volker Hall. The meeting, hosted by the UAB Marnix E. Heersink School of Medicine, focused on “Medicine in the Machine Age: The Integration and Influence of AI in Medicine,” and featured presentations and expert involvement from the Marnix E. Heersink Institute for Biomedical Innovation team and other Heersink School of Medicine leaders.

The Heersink School of Medicine Office of Research held its Annual Research Retreat on Tuesday, Feb. 6, at the UAB Alumni House. Research leadership from across Heersink, UAB Central Administration, other UAB schools, and Southern Research attended the retreat.

Michael Patton, an M.D.-Ph.D. student at the Heersink School of Medicine, received the 2023 New England Journal of Medicine scholarship for the Symposium on Artificial Intelligence for Learning Health Systems (SAIL) and gave a Spotlight Talk at the conference.

The Marnix E. Heersink Institute for Biomedical Innovation held a symposium titled "Generative AI for Healthcare: Progress or Peril" with multiple speakers, all innovators in the field of health care, on Tuesday, Sept. 12.

The project will empower a wide range of users to implement the next generation of genomic analysis, smart querying of medical literature, neuro-symbolic AI with stochastic reasoning, graph analytics, software verification tasks and security auditing.

Nathaniel Erdmann, M.D., Ph.D., Amit Gaggar, M.D., and Matthew Might, Ph.D., are the latest winners of the Heersink School of Medicine's Featured Discovery. This initiative celebrates important research from Heersink faculty members.

Camerron M. Crowder, Ph.D., professor in the Department of Neurobiology, has been awarded the 2023 Provost’s Awards for Faculty Excellence in Undergraduate Research.

The 10th annual Rare Disease Genomics Symposium will take place virtually March 10 from 8:30 a.m.-3:30 p.m.

Having a bacterial infection at the same time as COVID-19 is a greater risk factor for COVID-19 severity and mortality than previously described risk factors such as advanced age, male sex or various comorbidities.

Precision medicine approach may identify those at high genetic risk of hypertension, heart failure, stroke and heart attacks and use precision medicine to help prevent fatal cardiovascular diseases.